LGALS9 and hepatocellular carcinoma: In HCC, opposing effects of Galectin-9 have been described that are not well understood so far: while it is able to induce apoptosis in in vitro and in in vivo HCC models [74], it contributes to the immune exhaustion in HBV-associated HCC in patients and is a predictor for poor prognosis [72].